Free tool
Oncology stocks
We cover 271 companies grouped under the Oncology theme. The median market value in the group is $123.52M. Across the group, the median move over the past trading day is −0.05%. 48% of the 265 with a 200-day average trade above it. Price change over the past year runs from −76.8% to +188.2% across the middle 80 percent of the group, with a median of −5.6%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
271 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,874.50 JPY | −0.42% | −17.47% | −17.94% |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,462.50 JPY | −1.16% | +14.31% | +54.43% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% |
| COGT | Cogent Biosciences, Inc. | $36.72 | −9.71% | +5.70% | +196.85% |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% |
| 000100.KS | Yuhan Corporation | 83,100.00 KRW | +18.21% | −25.94% | −27.54% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| 000105.KS | Yuhan Corporation | 70,500.00 KRW | +19.09% | −30.38% | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | 15.68 AUD | +8.14% | +38.03% | +4.88% |
| TLX | Telix Pharmaceuticals Limited | $11.13 | +9.22% | +46.06% | −8.02% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% |
| NUVB | Nuvation Bio Inc. | $6.96 | +4.04% | −18.88% | +135.93% |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% |
| HCM.L | HUTCHMED (China) Limited | 179.00 GBP | +3.17% | −12.25% | −18.08% |
| HCM | HUTCHMED (China) Limited | $12.35 | +10.27% | −9.52% | −17.45% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.09 | +2.34% | −5.68% | +23.55% |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% |
| AAPG | Ascentage Pharma Group Internat | $16.90 | −7.57% | −35.91% | −59.18% |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AKTS | Aktis Oncology, Inc. | $26.51 | +15.41% | +18.35% | +18.35% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% |
| IMTX | Immatics N.V. | $9.43 | +7.96% | −9.76% | +74.63% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.38 | −34.75% | −6.07% | +207.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% |
| PHIL.MI | Philogen S.p.A. | 23.85 EUR | +1.06% | +6.10% | +4.75% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% |
| 4587.T | PeptiDream Inc. | 1,107.50 JPY | +16.74% | −31.68% | −27.31% |
| ANL | Adlai Nortye Ltd. | $15.06 | +18.68% | +991.30% | +791.12% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% |
| NVCT | Nuvectis Pharma, Inc. | $25.00 | +26.14% | +193.77% | +275.94% |
| AURA | Aura Biosciences, Inc. | $7.73 | +9.65% | +45.85% | +20.03% |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.26 | +7.80% | −24.65% | −0.43% |
| CTMX | CytomX Therapeutics, Inc. | $3.32 | +3.11% | −21.88% | +60.39% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| EIKN | Eikon Therapeutics, Inc. | $11.98 | +26.24% | −20.13% | −20.13% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| CBIO | Crescent Biopharma, Inc. | $18.02 | +9.61% | +62.64% | +26.46% |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| ARVN | Arvinas, Inc. | $9.32 | +13.66% | −18.74% | +15.35% |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.81 EUR | +8.00% | +386.49% | +1198.08% |
| RLMD | Relmada Therapeutics, Inc. | $4.55 | −13.00% | +4.12% | +579.10% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| CMPX | Compass Therapeutics, Inc. | $2.43 | +19.12% | −53.00% | −25.91% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% |
| FENC | Fennec Pharmaceuticals Inc. | $12.17 | +22.43% | +58.46% | +34.62% |
| GALT | Galectin Therapeutics Inc. | $4.15 | +22.42% | +2.47% | +4.27% |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% |
| FHTX | Foghorn Therapeutics Inc. | $6.69 | +30.41% | +28.90% | +23.66% |
| AGEN | Agenus Inc. | $8.25 | +25.00% | +155.42% | +81.72% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $3.89 | −15.80% | +183.94% | +113.74% |
| CATX | Perspective Therapeutics, Inc. | $3.16 | +10.10% | +13.26% | −12.47% |
| STRO | Sutro Biopharma, Inc. | $21.43 | −9.69% | +95.53% | +138.11% |
| IMRX | Immuneering Corporation | $5.15 | +21.46% | −22.21% | −0.77% |
| RAC.AX | Racura Oncology Ltd | 2.23 AUD | +12.06% | −22.30% | +87.39% |
| BCYC | Bicycle Therapeutics plc | $4.36 | +10.53% | −34.81% | −37.79% |
| PYXS | Pyxis Oncology, Inc. | $3.34 | +14.78% | +190.43% | +145.59% |
| WHWK | Whitehawk Therapeutics, Inc. | $4.84 | +31.52% | +98.36% | +167.40% |
| ALXO | ALX Oncology Holdings Inc. | $1.98 | −0.50% | +72.17% | +65.00% |
| CGEN | Compugen Ltd. | $2.84 | +25.66% | +83.23% | +93.20% |
| GLSI | Greenwich LifeSciences, Inc. | $18.23 | +35.54% | −6.37% | +56.21% |
| TNG.PA | Transgene SA | 0.81 EUR | +12.57% | −15.34% | −22.50% |
| ADAG | Adagene Inc. | $3.85 | +3.22% | +109.24% | +75.80% |
| MGNX | MacroGenics, Inc. Common Stock | $4.04 | +4.94% | +150.93% | +134.88% |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% |
| SPL.AX | Starpharma Holdings Limited | 0.73 AUD | −2.03% | +98.63% | +437.04% |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% |
| TARA | Protara Therapeutics, Inc. | $3.91 | −0.76% | −27.32% | +21.05% |
| CHRS | Coherus Oncology, Inc. | $1.45 | +0.69% | +5.84% | +27.19% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| NBP | NovaBridge Biosciences | $1.87 | +6.86% | −56.21% | −58.44% |
| CUE | Cue Biopharma, Inc. | $28.85 | −4.63% | +185.36% | +16.42% |
| MOLN | Molecular Partners AG | $4.45 | +16.19% | +5.45% | +18.67% |
| MENS | Jyong Biotech Ltd. | $2.24 | −6.28% | −34.31% | −95.62% |
| KZIA | Kazia Therapeutics Limited | $14.60 | +15.05% | +192.00% | +86.94% |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% |
| OKUR | OnKure Therapeutics, Inc. | $3.80 | −3.80% | +28.38% | +35.71% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| INDP | Indaptus Therapeutics, Inc. | $1.14 | −34.10% | −58.39% | −82.19% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| HURA | TuHURA Biosciences, Inc. | $2.13 | 0.00% | +184.00% | −26.55% |
| HPHA.DE | Heidelberg Pharma AG | 2.52 EUR | −2.70% | +0.80% | −31.15% |
| ADCT | ADC Therapeutics SA | $1.05 | −5.41% | −70.17% | −67.39% |
| BDTX | Black Diamond Therapeutics, Inc. | $2.27 | +28.98% | −8.84% | −20.91% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | 74.00 PLN | −0.80% | −1.33% | +80.49% |
| GNLX | Genelux Corporation | $2.73 | −6.51% | −40.00% | −25.00% |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% |
| NTHI | NeOnc Technologies Holdings, Inc. | $4.56 | +30.66% | −48.65% | −29.30% |
| RVU.WA | Ryvu Therapeutics S.A. | 18.40 PLN | +22.67% | −32.23% | −36.99% |
| 4889.T | Renascience Inc. | 1,309.00 JPY | −8.59% | −8.40% | −40.80% |
| FARN.L | Faron Pharmaceuticals Oy | 41.00 GBP | −4.65% | −78.97% | −79.24% |
| ONCY | Oncolytics Biotech Inc. | $0.86 | +8.30% | −12.69% | −19.28% |
| HBP.TO | Helix BioPharma Corp. | 1.94 CAD | +33.79% | −19.17% | +46.97% |
| 4575.T | CanBas Co., Ltd. | 840.00 JPY | +23.17% | +2.56% | −30.98% |
| ACRV | Acrivon Therapeutics, Inc. | $2.08 | +35.06% | −15.45% | +52.94% |
| 4579.T | RaQualia Pharma Inc. | 568.00 JPY | +25.39% | −41.56% | +3.46% |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% |
| MAIA | MAIA Biotechnology, Inc. | $1.39 | +12.10% | −13.13% | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.91 | −9.07% | −40.84% | −13.25% |
| CTOR | Citius Oncology, Inc. | $0.79 | +45.49% | −27.12% | −62.34% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| 4888.T | Stella Pharma Corporation | 353.00 JPY | +18.06% | +66.51% | −11.75% |
| ELTX | Elicio Therapeutics, Inc. | $2.98 | +1.02% | −62.98% | −71.29% |
| APLM | Apollomics, Inc. | $26.20 | +43.80% | +35.75% | +320.55% |
| OSTX | OS Therapies Incorporated | $1.65 | +10.00% | +23.13% | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $0.98 | +20.01% | −63.00% | −54.65% |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | +8.41% | −7.20% | −31.36% |
| XBIT | XBiotech Inc. | $2.31 | +1.76% | −2.94% | −33.62% |
| SAR.L | Sareum Holdings plc | 37.00 GBP | +76.19% | +117.65% | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| MAAT.PA | MaaT Pharma SA | 3.04 EUR | +8.96% | −45.52% | −33.91% |
| XLO | Xilio Therapeutics, Inc. | $9.05 | −1.09% | −3.81% | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $0.31 | −36.29% | −75.22% | −77.04% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +11.54% | −14.71% | −14.71% |
| IMM.AX | Immutep Limited | 0.05 AUD | +8.51% | −88.14% | −79.18% |
| 4572.T | Carna Biosciences, Inc. | 402.00 JPY | +37.67% | 0.00% | +81.90% |
| TIL | Instil Bio, Inc. | $7.83 | +7.41% | −30.52% | −72.04% |
| 4597.T | Solasia Pharma K.K. | 30.00 JPY | +3.45% | +7.14% | −18.92% |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −17.28% | −19.28% | +63.41% |
| IBO | Impact BioMedical Inc. | $0.44 | +2.35% | −15.20% | −24.12% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −9.52% | −20.83% | −26.92% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| SVE.WA | Synthaverse S.A. | 3.06 PLN | +9.29% | −20.21% | −36.25% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +15.22% | +8.16% | −39.08% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.96 | −72.36% | −72.74% | −74.90% |
| 4583.T | Chiome Bioscience Inc. | 86.00 JPY | +26.47% | −19.63% | −36.76% |
| MOC.WA | Molecure S.A. | 6.03 PLN | −2.58% | −8.08% | −22.39% |
| CNTX | Context Therapeutics Inc. | $0.42 | −28.31% | −72.66% | −50.73% |
| 206A.T | PRISM BioLab Co.,LTD | 170.00 JPY | +18.06% | +5.59% | −5.56% |
| SNT.AX | Syntara Limited | 0.03 AUD | +22.73% | −20.59% | +1.89% |
| BCT.TO | BriaCell Therapeutics Corp. | 5.62 CAD | +15.64% | −42.77% | −46.48% |
| BCTX | BriaCell Therapeutics Corp. | $4.03 | +16.14% | −43.79% | −46.97% |
| 190A.T | CHORDIA THERAPEUTICS INC | 72.00 JPY | −1.37% | −35.71% | −59.32% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| ATNM | Actinium Pharmaceuticals, Inc. | $1.01 | +16.49% | −26.28% | −42.61% |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +32.39% | −53.00% | −56.48% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −4.55% | −30.00% | −57.43% |
| BYSI | BeyondSpring Inc. | $0.69 | −41.77% | −57.14% | −62.09% |
| CVM | CEL-SCI Corporation | $1.61 | +34.17% | −68.74% | −87.65% |
| NNG.WA | NanoGroup S.A. | 2.38 PLN | −4.80% | −11.19% | −17.36% |
| LTRN | Lantern Pharma Inc. | $2.18 | −16.15% | −29.90% | −46.17% |
| NXTC | NextCure, Inc. | $5.83 | +7.56% | −56.10% | +11.37% |
| EVAX | Evaxion A/S | $3.24 | +15.71% | −31.21% | +6.93% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.07% | −72.59% | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $2.65 | +9.50% | −71.96% | −76.75% |
| IMU.AX | Imugene Limited | 0.07 AUD | −17.65% | −82.05% | −75.00% |
| MRKR | Marker Therapeutics, Inc. | $1.45 | +22.88% | −5.84% | +54.26% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +1.60% | −26.80% | −47.30% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| CCM | Concord Medical Services Holdings Limited | $4.96 | +7.83% | +16.16% | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $1.34 | +13.56% | +17.54% | −15.72% |
| DEX.ST | Dextech Medical AB | 10.30 SEK | −0.96% | +11.35% | +26.38% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −2.17% | −4.26% | −10.00% |
| ABVC | ABVC BioPharma, Inc. | $0.71 | −32.92% | −67.53% | −76.14% |
| RADX | Radiopharm Theranostics Limited | $2.32 | −29.91% | −55.04% | −58.87% |
| ALTME.PA | TME Pharma N.V. | 0.13 EUR | +113.11% | +88.41% | +25.97% |
| TPST | Tempest Therapeutics, Inc. | $1.08 | +24.00% | −63.39% | −89.96% |
| AKTX | Akari Therapeutics, Plc | $9.10 | +7.95% | −21.55% | −72.42% |
| ABERA.ST | Abera Bioscience AB | 8.18 SEK | −2.62% | +13.61% | +1.61% |
| B8FK.DE | Biofrontera AG | 2.53 EUR | −0.78% | −0.78% | −3.07% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +4.93% | −34.65% | −56.56% |
| MDCX | Medicus Pharma Ltd. | $0.27 | −4.11% | −83.22% | −86.77% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −28.57% | −60.00% | −63.64% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.58 | +15.88% | −31.95% | −57.88% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +50.00% | −11.22% | −30.40% |
| INTS | Intensity Therapeutics, Inc. | $4.53 | −0.44% | −55.48% | −40.00% |
| ACTI.ST | Active Biotech AB (publ) | 5.50 SEK | +6.38% | +19.57% | −62.00% |
| PHIO | Phio Pharmaceuticals Corp. | $1.20 | +18.81% | +10.09% | −40.89% |
| GTBP | GT Biopharma, Inc. | $0.29 | −8.49% | −64.49% | −74.55% |
| PDSB | PDS Biotechnology Corporation | $0.22 | −67.70% | −73.21% | −82.56% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% |
| MBRX | Moleculin Biotech, Inc. | $0.60 | −72.60% | −83.43% | −96.05% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +15.81% | −6.46% | −42.10% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +9.47% | −80.92% | −81.75% |
| IMNN | Imunon, Inc. | $1.63 | +6.54% | −58.73% | −73.10% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.44 | +7.30% | +2.64% | −13.51% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +4.17% | −78.34% | −89.69% |
| BOLT | Bolt Biotherapeutics, Inc. | $3.92 | −2.49% | −32.30% | −26.73% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.06% | −24.55% | −74.85% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | 0.32 EUR | +2.57% | −18.41% | −19.44% |
| CHOSA.ST | Chosa Oncology AB | 0.73 SEK | −14.15% | −20.00% | −9.00% |
| ITOC | iTonic Holdings Ltd. | $0.29 | +11.89% | −33.23% | −59.75% |
| NCNA | NuCana plc | $1.53 | +18.60% | −57.97% | −52.78% |
| LIMN | Liminatus Pharma, Inc. | $4.41 | +4140.38% | +587.99% | +46.03% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.13 | −30.16% | −27.30% | −60.00% |
| KAPA | Kairos Pharma, Ltd. | $0.26 | −15.58% | −64.33% | −77.97% |
| NFX.L | Nuformix plc | 0.16 GBP | +6.71% | −46.10% | +80.68% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +66.67% | −47.37% | −54.55% |
| BCAB | BioAtla, Inc. | $3.12 | −11.61% | −88.31% | −86.04% |
| HCWB | HCW Biologics Inc. | $2.70 | +4.45% | +141.07% | −55.15% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
| APVO | Aptevo Therapeutics Inc. | $2.41 | −42.76% | −74.33% | −92.52% |
| OSRH | OSR Health, Inc. | $0.17 | −63.24% | −71.48% | −80.93% |
| CRIS | Curis, Inc. | $1.54 | −68.12% | +57.14% | −5.52% |
| RDHL | RedHill Biopharma Ltd. | $0.62 | −15.71% | −40.26% | −53.74% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | 0.16 SEK | +30.42% | +16.79% | +11.79% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.35 | −21.14% | +14.41% | −19.16% |
| GOVX | GeoVax Labs, Inc. | $0.63 | −13.33% | −87.82% | −96.67% |
| ARTL | Artelo Biosciences, Inc. | $0.71 | −19.25% | −81.35% | −97.37% |
| IVX.AX | Invion Limited | 0.04 AUD | −18.18% | −61.29% | −72.31% |
| PPBT | Purple Biotech Ltd | $1.73 | +26.28% | −73.79% | −92.21% |
| VAL.L | ValiRx plc | 0.16 GBP | +3.33% | −57.53% | −73.04% |
| RNAZ | TransCode Therapeutics, Inc. | $2.34 | −53.20% | −68.38% | −76.72% |
| PPCB | Propanc Biopharma, Inc. | $1.07 | −11.57% | −92.51% | −98.54% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
| SLXN | Silexion Therapeutics Corp | $0.35 | −85.51% | −81.12% | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $3.01 | −25.50% | −61.53% | −95.78% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| BDRX | Biodexa Pharmaceuticals Plc | $0.98 | −32.13% | −92.05% | −96.58% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.